# US 2017/0319615 A1 · Heparan sulphates for use in repair and/or regeneration of skin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0319615 A1
- Document ID: US20170319615A1
- Status: Published application
- Kind: A1
- Application number: 15/527,972
- Filed: 2015-11-19
- Published: 2017-11-09
- Earliest claimed: 2014-11-19
- Assignees: Agency for Science, Technology and Research
- Applicants: Agency for Science, Technology and Research
- Inventors: Simon Cool; Victor Nurcombe
- Web page: https://patentgrep.com/patent/US20170319615A1

## CPC

- A61K 31/727: Heparin; Heparan
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A61K 38/1825: {Fibroblast growth factor [FGF]}
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 26/0023: {Polysaccharides}
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- C08B 37/0075: {Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)

## Abstract

Affinity purification of fibroblast growth factor 2-binding heparan sulphate from porcine mucosa (HS8) is disclosed. Also disclosed is the use of HS8 in repair and regeneration of the skin for treating wounds, burns, ulcers and other skin injuries.

## Claims

### Claim 1

Heparan sulphate HS8 for use in a therapeutic method of repair and/or regeneration of skin.

### Claim 2

Use of Heparan sulphate HS8 in the manufacture of a medicament for use in a therapeutic method of repair and/or regeneration of skin.

### Claim 3 (depends on 1, 2)

HS8 for use in a therapeutic method of repair and/or regeneration of skin of claim 1 or the use of claim 2 wherein the therapeutic method involves treatment of a skin wound or scar, optionally selected from skin burns, ulcers, excisional wounds, cut, stab or puncture wounds.

### Claim 4 (depends on 1, 2)

HS8 for use in a therapeutic method of repair and/or regeneration of skin of claim 1 or the use of claim 2 wherein the therapeutic method involves skin graft healing, skin reconstruction, or skin plastic surgery.

### Claim 5

A method of healing a skin wound comprising contacting the skin wound with an effective amount of a pharmaceutical composition comprising heparan sulphate HS8.

### Claim 6

A method of treating a subject having a skin wound, the method comprising administration of a therapeutically effective amount of heparan sulphate HS8 to the subject leading to repair and/or regeneration of skin at the wound.

### Claim 7 (depends on 5, 6)

The method of claim 5 or 6 wherein the skin wound is a skin burn, ulcer, excisional wound, cut, stab or puncture wound

### Claim 8

A method of skin grafting, skin reconstruction, or skin plastic surgery comprising contacting the skin at or adjacent the region of grafting, reconstruction or plastic surgery with an effective amount of a pharmaceutical composition comprising HS8.

### Claim 9

HS8 for use in a therapeutic method of repair and/or regeneration of skin, the use or the method of any one of the preceding claim wherein the HS8, medicament or pharmaceutical composition is formulated for topical or transdermal administration.

### Claim 10

HS8 for use in a therapeutic method of repair and/or regeneration of skin, the use or the method of any one of the preceding claim wherein the HS8, medicament or pharmaceutical composition is formulated as a gel, spray, paste, ointment, cream, lotion, salve, oil, aqueous solution, suspension, dispersion, patch, adhesive plaster, bandage, dressing, depot, or reservoir.

### Claim 11

HS8 for use in a therapeutic method of repair and/or regeneration of skin, the use or the method of any one of the preceding claims wherein the method further comprises administration of a growth factor, preferably FGF2, and/or mesenchymal stem cells.

### Claim 12

HS8 for use in a therapeutic method of repair and/or regeneration of skin, the use or the method of any one of the preceding claims wherein the HS8, medicament or pharmaceutical composition is formulated as a combined preparation with a growth factor, preferably FGF2, and/or with mesenchymal stem cells.

### Claim 13

HS8 for use in a therapeutic method of repair and/or regeneration of skin, the use or the method of any one of the preceding claims wherein the heparan sulphate HS8 is provided in isolated or substantially purified form.

### Claim 14

HS8 for use in a therapeutic method of repair and/or regeneration of skin, the use or the method of any one of the preceding claims wherein the heparan sulphate HS8 is capable of binding a peptide or polypeptide having, or consisting of, the amino acid sequence YCKNGGF (SEQ ID NO:2) or GHFKDPKRLYCKNGGF (SEQ ID NO:1).

### Claim 15

HS8 for use in a therapeutic method of repair and/or regeneration of skin, the use or the method of any one of the preceding claims wherein following digestion with heparin lyases I, II and III and then subjecting the resulting disaccharide fragments to capillary electrophoresis analysis the heparan sulphate HS8 has a disaccharide composition comprising:
Disaccharide
Normalised weight percentage
ΔUA,2S-GlcNS,6S
12.7 ± 3.0
ΔUA,2S-GlcNS
7.2 ± 2.0
ΔUA-GlcNS,6S
15.5 ± 3.0
ΔUA,2S-GlcNAc,6S
6.5 ± 2.0
ΔUA-GlcNS
15.7 ± 3.0
ΔUA,2S-GlcNAc
1.0 ± 0.5
ΔUA-GlcNAc,6S
8.9 ± 3.0
ΔUA-GlcNAc
32.5 ± 3.0

### Claim 16

HS8 for use in a therapeutic method of repair and/or regeneration of skin, the use or the method of any one of the preceding claims wherein the HS8 is obtained by a method comprising:
(i) providing a solid support having polypeptide molecules adhered to the support, wherein the polypeptide comprises a heparin-binding domain having the amino acid sequence YCKNGGF;
(ii) contacting the polypeptide molecules with a mixture comprising glycosaminoglycans such that polypeptide-glycosaminoglycan complexes are allowed to form;
(iii) partitioning polypeptide-glycosaminoglycan complexes from the remainder of the mixture;
(iv) dissociating glycosaminoglycans from the polypeptide-glycosaminoglycan complexes;
(v) collecting the dissociated glycosaminoglycans.
